Aviz Joins the Linux Foundation and Announces Free Support for SONiC Evaluations in The Enterprise
Free support with community grade SLA for all major switch platforms enables users to rapidly…
News
Mitsubishi Power’s Emerald Storage Solutions to Help SDG&E Power Critical Public Services
180 Megawatt-hour Microgrid Storage Will Provide Emergency Backup and Increase Capacity LAKE MARY, Fla.–(BUSINESS WIRE)–#BESS–San…
Althea Announces the “Unlock Connectivity Grant 2022” for a Creative Approach to Connectivity in Challenging Areas Using KeyLTE
CLATSKANIE, Ore.–(BUSINESS WIRE)–#AltheaSmart—Althea announces the “Unlock Connectivity Grant 2022” for a creative approach to connectivity…
Datawisp Closes $3.6M Seed Round Led by CoinFund to Expand its B2B no-code Data Platform for Web3 and Web2
NEW YORK–(BUSINESS WIRE)–Datawisp, a no-code data exploration platform focused on web3 and gaming, has raised…
Tanium Ranked in Top 25 of the Forbes Cloud 100 List for Seventh Consecutive Year
Company recognized as a leader every year since list’s inception for standout performance in cloud…
Paige Announces Partnership with Sonora Quest Laboratories to Accelerate Precision Diagnostics for Patients Across Arizona
Custom platform tailored to needs of market leader in clinical diagnostics to facilitate better integration,…
Aeromexico Selects Pricefx to Enhance Sales Analytics Capabilities and Drive Additional Value from their Travel Agency Channel
Mexico’s flagship airline will initially use Pricefx for its agency business with plans to expand…
Cherre and Fortimize Announce Strategic Alliance
NEW YORK–(BUSINESS WIRE)–Cherre, the industry’s leading real estate data management and analytics platform, and Fortimize,…
CRN Honors Arcserve’s CEO Brannon Lacey as an Innovator on its 2022 Top 100 Executives List
CRN’s annual list recognizes forward-thinking technology leaders who are dedicated to the channel and taking…
Infovista to showcase new Ativa™ Automated Assurance & Operations solutions at Digital Transformation World 2022
Enables 360° Assurance and multi-phase automation use cases from a single platform for the first…
Panbela Announces First Patient Enrolled in its Aspire Trial Studying SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma
Expects interim data by early 2024 MINNEAPOLIS, Aug. 11, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics,…
Zealand Pharma Announces Financial Results for the First Half of 2022
Company Announcement No. 34 / 2022 Interim report for H1 2022 Zealand Pharma Announces Financial…
Landos Biopharma Reports Second Quarter 2022 Results and Provides Business Update
Positive Top-Line Results From NX-13 Phase 1b Trial in Ulcerative Colitis Demonstrate a Favorable Safety…
Monopar Therapeutics Reports Second Quarter 2022 Financial Results and Recent Program Developments
Validive® Phase 2b/3 VOICE Trial Continues Adding Sites in the U.S. and Europe and Enrolling…
aTyr Pharma Receives FDA Fast Track Designation for Efzofitimod (ATYR1923) for Treatment of Pulmonary Sarcoidosis
Company is investigating efzofitimod in global pivotal Phase 3 EFZO-FIT™ study in pulmonary sarcoidosis patients…
89bio Reports Second Quarter 2022 Financial Results and Provides Corporate Update
– Reported positive topline results from ENTRIGUE Phase 2 trial of pegozafermin in severe…
Synthetic Biologics Reports Second Quarter 2022 Operational Highlights and Financial Results
-Prioritizing the advancement of novel oncolytic adenovirus (OV) platform- -Cash balance as of August 1,…
Enzo Biochem to Launch Monkeypox Testing Services this Week
NEW YORK, NY, Aug. 11, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo”…
Surrozen Reports Second Quarter 2022 Financial Results
Phase 1 clinical trials of SZN-1326 and SZN-043 initiated and ongoing Preclinical proof-of-concept data for…
Fortress Biotech Subsidiary Helocyte Announces Grant that Could Provide Over $20 Million from National Institute of Allergy and Infectious Diseases for Phase 2 Study of Triplex for Control of Cytomegalovirus in Patients Undergoing Liver Transplantation
MIAMI, Aug. 11, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…